Evidence map›Paper›PMID 30285629›Full record

ArticleGenetics, selection, evolution : GSE2018

Derivation of the economic value of R

Kasper Janssen, Hans Komen, Helmut W Saatkamp, Mart C M de Jong, Piter Bijma

Open access · goldAbstract read
In one paragraph

Article in Genetics, selection, evolution : GSE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. The economic value of RGenetics, selection, evolution : GSE · 2020
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kasper JanssenAnimal Breeding and Genomics, Wageningen University and Research, P.O. Box 338, 6708 PB, Wageningen, The Netherlands. kasper.janssen@wur.nl.ORCID http://orcid.org/0000-0002-8860-8226
Hans KomenAnimal Breeding and Genomics, Wageningen University and Research, P.O. Box 338, 6708 PB, Wageningen, The Netherlands.
Helmut W SaatkampBusiness Economics, Wageningen University and Research, P.O. Box 8130, 6706 KN, Wageningen, The Netherlands.
Mart C M de JongQuantitative Veterinary Epidemiology, Wageningen University and Research, P.O. Box 338, 6708 PB, Wageningen, The Netherlands.
Piter BijmaAnimal Breeding and Genomics, Wageningen University and Research, P.O. Box 338, 6708 PB, Wageningen, The Netherlands.
Wageningen University & Research · NLCentre for BioSystems Genomics · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMacroparasites, such as ticks, lice, and helminths, are a concern in livestock and aquaculture production, and can be controlled by genetic improvement of the host population. Genetic improvement should aim at reducing the rate at which parasites spread across the farmed population. This rate is determined by the basic reproduction ratio, i.e. [Formula: see text], which is the appropriate breeding goal trait. This study aims at providing a method to derive the economic value of [Formula: see text].

methodsCosts of a disease are the sum of production losses and expenditures on disease control. Genetic improvement of [Formula: see text] lowers the loss-expenditure frontier. Its economic effect depends on whether the management strategy is optimized or not. The economic value may be derived either from the reduction in losses with constant expenditures or from the reduction in expenditures with constant losses.

resultsWhen [Formula: see text] ≤ 1, the economic value of a further reduction is zero because there is no risk of a major epidemic. When [Formula: see text] > 1 and management is optimized, the economic value increases with decreasing values of [Formula: see text], because both the mean number of parasites per host and frequency of treatments decrease at an increasing rate when [Formula: see text] decreases. When [Formula: see text] > 1 and management is not optimized, the economic value depends on whether genetic improvement is used for reducing expenditures or losses. For sea lice in salmon, the economic value depends on a reduction in expenditures with constant losses, and is estimated to be 0.065€/unit [Formula: see text]/kg production. DISCUSSION: Response to selection for measures of disease prevalence cannot be predicted from quantitative genetic theory alone. Moreover, many studies fail to address the issue of whether genetic improvement results in reduced losses or expenditures. Using [Formula: see text] as the breeding goal trait, weighed by its appropriate economic value, avoids these issues.

conclusionWhen management is optimized, the economic value increases with decreasing values of [Formula: see text] (until the threshold of [Formula: see text], where it drops to zero). When management is not optimized, the economic value depends on whether genetic improvement is used for reduced expenditures or production losses. For sea lice in salmon, the economic value is estimated to be 0.065 €/unit [Formula: see text]/kg production.

Indexed as

Cost of IllnessAnimalsCopepodaFish DiseasesParasitic DiseasesReproductionSalmonSelective Breeding

Identifiers

PMID30285629
PMCPMC6171287
OpenAlexW2895147667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.